Anzeige
Mehr »
Login
Freitag, 10.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Innocan Pharma News: Unfassbare Studie - LPT-Therapie bewahrt Patient vor dem Tod!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
53 Leser
Artikel bewerten:
(0)

AMERIGROUP Names Mary McCluskey, MD, Chief Medical Officer

VIRGINIA BEACH, Va., Sept. 17 /PRNewswire-FirstCall/ -- AMERIGROUP Corporation today announced that Mary McCluskey, MD, has been named Chief Medical Officer to oversee healthcare services for the Company's 1.5 million members.

"We are excited to welcome Dr. McCluskey to AMERIGROUP," said James G. Carlson, AMERIGROUP President and Chief Executive Officer. "Throughout her career, she has distinguished herself as an attending clinician, physician executive and leader of a major healthcare organization. She has the experience and the commitment to help AMERIGROUP expand its mission of bringing quality healthcare to the financially vulnerable, seniors and people with disabilities."

"I'm honored to join such an experienced team and to assist AMERIGROUP and the 1.5 million members it serves," McCluskey said. "This is an exciting time for the Company, and I look forward to contributing to its efforts of bringing quality care and service coordination to those who need it most."

For the past eight years, Dr. McCluskey has served in a variety of senior medical positions with Aetna Inc., most recently as Chief Medical Officer, Northeast Region. In this role, she was the senior clinical and medical quality leader for a division that provided health insurance for 2.4 million people through employer-sponsored and Medicare programs. Under her guidance, the company's Northeast region earned an excellent accreditation rating from the National Committee for Quality Assurance. Her previous positions at Aetna included National Medical Director/Head of Clinical Cost Management and Senior Regional Medical Director, Southeast Region.

Prior to Aetna, McCluskey was Vice President of Medical Affairs for Medpartners Medical Management in Tampa. She previously served as Internist/Medical Director of Bridgeton Health Center in St. Louis. McCluskey began her career as an Urgent Care Physician in St. Louis. A graduate of St. Louis University and the St. Louis University School of Medicine, she completed her residency in Internal Medicine at Jewish Hospital/Washington University in St. Louis.

AMERIGROUP offers disease management programs for 11 different conditions, ranging from asthma and diabetes to AIDS and schizophrenia, eight of which are accredited by the National Committee for Quality Assurance. The Company's health plan in the District of Columbia has also obtained accreditation and a rating of commendable from the NCQA. All AMERIGROUP health plans in the District and nine states offer members a range of initiatives that are designed to connect the 1.5 million members with quality, preventive healthcare programs that target the specific needs of low-income Americans.

About AMERIGROUP Corporation

AMERIGROUP Corporation, headquartered in Virginia Beach, Virginia, improves healthcare access and quality for the financially vulnerable, seniors and people with disabilities by developing innovative managed health services for the public sector. Through its subsidiaries, AMERIGROUP Corporation serves more than 1.5 million people in the District of Columbia, Florida, Georgia, Maryland, New Jersey, New York, Ohio, Tennessee, Texas and Virginia. For more information, visit http://www.amerigroupcorp.com/ .

CONTACTS: Investors: Julie Loftus Trudell News Media: Kent Jenkins, Jr. AMERIGROUP Corporation AMERIGROUP Corporation Senior Vice President, Senior Vice President, Investor Relations Communications (757) 321-3597 (757) 518-3671

Lithium vs. Palladium - Ist das die Chance des Jahrzehnts?
Sichern Sie sich den kostenlosen PDF-Report! So können Sie vom Boom der Rohstoffe profitieren.
Hier klicken
© 2007 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.